A new mechanism of leukemia drug resistance?
Williams
David A
DA
Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use*; D001216:Asparagine / Q000187:drug effects; D001217:Aspartate-Ammonia Ligase / Q000096:biosynthesis / Q000502:physiology*; D001854:Bone Marrow Cells / Q000378:metabolism*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D001216:Asparagine; D001215:Asparaginase; D001217:Aspartate-Ammonia Ligase